Medfinder
Back to blog

Updated: January 25, 2026

What Is Tresiba? Uses, Dosage, and What You Need to Know in 2026

Author

Peter Daggett

Peter Daggett

Tresiba insulin bottle with information icon and educational elements

Tresiba (insulin degludec) is an ultra-long-acting basal insulin for type 1 and type 2 diabetes. Here's everything you need to know about how it works, how to take it, and what to expect.

Tresiba is a prescription insulin used every day by hundreds of thousands of people with diabetes across the United States. If you've just been prescribed Tresiba or are considering it, you probably have questions: What exactly is it? How does it work? How do you take it? And is it right for you?

This guide covers everything a patient needs to know about Tresiba in plain English — no medical jargon, just clear facts.

What Is Tresiba?

Tresiba is the brand name for insulin degludec, an ultra-long-acting basal insulin analog manufactured by Novo Nordisk. It was FDA-approved on September 25, 2015, and has been available in US pharmacies since January 2016. It is included on the World Health Organization's List of Essential Medicines.

"Basal" insulin means it works in the background — it provides a steady, low-level supply of insulin throughout the day and night to keep your blood sugar stable between meals and while you sleep. Tresiba is not a mealtime insulin and does not provide the quick burst of insulin needed after eating. Many people with diabetes take both a basal insulin (like Tresiba) and a rapid-acting mealtime insulin as part of a complete regimen.

What Is Tresiba Used For?

Tresiba is FDA-approved to improve glycemic control (blood sugar management) in:

Adults with type 1 diabetes (used with a mealtime insulin)

Adults with type 2 diabetes (used alone or with other diabetes medications)

Children aged 1 year and older with type 1 or type 2 diabetes

Tresiba is NOT for: Treating diabetic ketoacidosis (DKA), use in an insulin pump, or intravenous administration.

What Makes Tresiba Different from Other Basal Insulins?

Tresiba stands out from other long-acting insulins for two key reasons:

Ultra-long duration (42+ hours): Most long-acting insulins last 18-24 hours. Tresiba lasts over 42 hours — the longest of any currently marketed insulin. This means even if you occasionally miss a dose or take it a few hours late, the insulin remains active.

No peak: Tresiba has no pronounced activity peak. It provides a flat, steady glucose-lowering effect throughout the day. The DEVOTE trial showed this reduces severe hypoglycemia risk by 40% vs. insulin glargine in type 2 diabetes patients. Fewer nighttime lows is a key benefit for many patients.

Available Forms and Strengths

FlexTouch U-100 pen (100 units/mL): 3 mL per pen, sold in boxes of 5 pens. Doses from 1 to 80 units in 1-unit increments.

FlexTouch U-200 pen (200 units/mL): 3 mL per pen, sold in boxes of 3 pens. Doses from 2 to 160 units in 2-unit increments. Good for patients who need higher doses.

Vial U-100 (100 units/mL): 10 mL vial for use with a U-100 insulin syringe. Used for children requiring less than 5 units/day or patients who prefer syringes.

How to Take Tresiba

Once daily: Inject under the skin (subcutaneously) once per day. You can take it at any time of day, as long as at least 8 hours have passed since your last dose.

Flexible timing: Unlike some insulins that must be taken at the exact same time each day, Tresiba's ultra-long duration allows some flexibility. Consistency is still preferred, but if you miss your usual time by a few hours, just take it as soon as you remember.

Injection sites: Abdomen (at least 2 inches from navel), outer thighs, or outer back of upper arms. Rotate sites at every injection.

Storage: Unopened pens and vials: refrigerator until expiration, OR room temperature (below 86°F/30°C) for up to 56 days. Do not freeze.

Typical Starting Doses

Type 1 diabetes (insulin-naive): 30-50% of total daily insulin dose once daily

Type 2 diabetes (insulin-naive): 10 units once daily

Switching from another basal insulin: Adults: same unit dose as your current basal insulin. Children: 80% of the current dose.

Your doctor will tailor your dose based on your blood sugar readings and will adjust over time. Never change your insulin dose without consulting your healthcare provider.

Availability and Finding Tresiba in Stock

Tresiba has experienced intermittent supply shortages in 2025-2026. If you can't find it at your usual pharmacy, medfinder can help you find which pharmacies near you have it in stock. It checks multiple pharmacies at once and texts you the results, saving you hours of calling around.

To learn more about side effects, see: Tresiba Side Effects: What to Expect and When to Call Your Doctor.

Frequently Asked Questions

Tresiba (insulin degludec) is used to improve blood sugar control in adults and children (aged 1 and older) with type 1 or type 2 diabetes mellitus. It is a once-daily basal (background) insulin injected under the skin. It is not used for diabetic ketoacidosis or as a mealtime insulin.

Tresiba is an ultra-long-acting basal insulin. Its effects last over 42 hours after a single injection — the longest duration of any currently marketed insulin. It has no activity peak, providing a smooth, stable level of insulin throughout the day.

Tresiba is injected once daily, at any time of day, as long as at least 8 hours have passed since the previous dose. Its ultra-long duration provides flexibility in timing — if you miss your usual time, take it as soon as you remember and then return to your regular schedule.

Yes. Tresiba is FDA-approved for children aged 1 year and older with type 1 or type 2 diabetes. For children who need less than 5 units per day, the U-100 vial should be used for more accurate dosing.

Both U-100 and U-200 contain the same insulin degludec, just at different concentrations. U-100 has 100 units per mL, and U-200 has 200 units per mL. The U-200 pen holds more insulin in the same volume, making it convenient for patients who need larger doses. The U-100 pen doses in 1-unit increments; U-200 doses in 2-unit increments.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Tresiba also looked for:

31,889 have already found their meds with Medfinder.

Start your search today.

31K+
5-star ratingTrusted by 31,889 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?